1. Signaling Pathways
  2. Stem Cell/Wnt
  3. SDCBP

SDCBP (MDA-9/Syndecan 结合蛋白 (SDCBP))

Syntenin Syndecan Binding Protein (SDCBP)/MDA-9

黑色素瘤分化相关基因-9 (mda-9),也称为 Syntenin-1 或 Syndecan 结合蛋白 (SDCBP) 或 Pro-TGF-α 细胞质结构域相互作用蛋白。从结构上看,MDA-9/Syntenin 有四个结构域,即 N 端或 NTD(1-109 aa)、两个串联 PDZ 结构域、PDZ1 和 PDZ2(分别为氨基酸 110-193 和氨基酸 194-273)和一个短羧基末端结构域 (CTD)。从生物学上讲,与 NTD 和 CTD 结构域在癌症转移方面的作用相比,PDZ 结构域的功能描述得更好[1]mda-9/Syntenin 的优先表达在组织学上不同的肿瘤中明显,并有助于转移过程中的几个步骤。这些包括肿瘤细胞侵袭和迁移、通过分泌促血管生成因子诱导血管生成、增强上皮-间质转化 (EMT)、调节影响细胞粘附过程的整合素表达、外泌体的生物合成和外泌体介导的细胞间通讯信号传导,以及最近抑制宿主免疫监视的免疫调节[2]

Melanoma differentiation associated gene-9 (mda-9), also known as Syntenin-1 or Syndecan Binding Protein (SDCBP) or Pro-TGF-α Cytoplasmic Domain-Interacting Protein. Structurally, MDA-9/Syntenin has four domains, i.e., N-terminal or NTD (1-109 aa), two tandem PDZ domains, PDZ1 and PDZ2 (amino acid 110-193 and amino acid 194-273, respectively) and a short carboxyl-terminal domain (CTD). Biologically, the function of PDZ domains are better described as compared to the roles of the NTD and CTD domains with respect to cancer metastasis[1]. Preferential elevated expression of mda-9/Syntenin is evident in histologically distinct tumors and contributes to several steps in the metastatic process. These include tumor cell invasion and migration, induction of angiogenesis through secretion of proangiogenic factors, enhancement of epithelial–mesenchymal transition (EMT), regulation of the expression of integrins affecting cell-adhesion processes, exosome biogenesis and exosome-mediated signaling in cell–cell communication, and recently immune-modulation suppressing host-immune surveillance[2].

SDCBP 相关产品 (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-156247
    IVMT-Rx-3 Inhibitor
    IVMT-Rx-3 是一种靶向 MDA-9/Syntenin 的 PDZ1PDZ2 结构域的 SDCBP 抑制剂。IVMT-Rx-3 阻断 MDA-9/Syntenin与Src 的相互作用,降低 NF-κB 的活化,抑制 MMP-2/MMP-9 的表达。IVMT-Rx-3 抑制黑色素瘤转移。
    IVMT-Rx-3